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Chapter 1. Background 
DNA and the damage that can occur to it 
 
All living organisms contain DNA which is responsible for the genetic code 
that dictates the development and functioning of living organisms. DNA is a 
polymer that is composed of an alternating sugar (deoxyribose) and phosphate 
backbone linked by ester bonds. Attached to each sugar group is one of four 
possible nucleoside bases: adenine (A), thymine (T), cytosine (C) or guanine 
(G). The bases can be subdivided into two groups: purines (adenine and 
thymine) and pyrimidines (cytosine and guanine). A purine base is always 
bound to its corresponding pyrimidine base through hydrogen bonds (A binds 
to T and C binds to G).  The base sequences can code for proteins that are 
responsible for various structures or processes within the cell (38).  
When a cell is exposed to radiation, stress or toxic chemicals lesions in the 
DNA can occur. These lesions include: adducts, thymine dimers, single and 
double strand breaks (SSB and DSB respectively). DNA adducts occur when 
DNA is covalently bound to a foreign chemical. Since the DNA forms a new 
bond to the foreign chemical, old bonds are broken, which lead to improper 
nucleotide binding. Thymine dimers are caused by ultra violet (UV) light 
exposure. The UV light is absorbed by thymine and can lead to a double bond 
 2
between two adjacent thymine nucleotides. Single and double strand breaks are 
when one or both DNA strands have a complete break in the strand. Having 
damaged DNA is extremely dangerous for the cell and often interferes with the 
cell cycle (17, 22, 40).  
The cell cycle is divided into four stages: G1, S, G2 and M; as shown in 
figure 1. G1 (gap1) is the first growth phase where the cell absorbs nutrients 
and will grow in size. Eventually the cell will grow enough and enter S phase. 
During S (synthesis) phase the cell replicates its DNA so that it has two copies 
of each chromosome. Following S phase there is a G2 (gap 2) phase where the 
cell continues to grow. Eventually the cell will be large enough to enter M 
phase. During M phase the cell undergoes mitosis and divides into two cells 
(38).  
The cell cycle is regulated by proteins called cyclins and cyclin-dependent 
kinases (CDK).  Cyclins are the regulatory subunit of the hetero-dimeric 
protein kinase that regulates the cell cycle. CDK’s are the catalytic subunit, but 
they cannot function without their proper cyclin. Once a CDK binds with its 
corresponding cyclin the complex becomes activated and can de/phosphorylate 
other proteins, which in turn can cause the cell to enter the next phase of the 
cell cycle (12, 23). 
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Figure 1. Cell growth and division cycle. All normal cells follow the 
same cycle of: growth, replication of DNA, more growth then division.  
[http://bhs.smuhsd.org/bhsnew/academicprog/science/vaughn/Student%20Projects/Paul%20&%20Mar
cus/Cell_Replication.html] 
 
 
Adducts in the strand can interfere with DNA replication or transcription, 
which can result in several consequences. If an error occurs in the replication 
process it can result in improper replication, leading to mutated DNA or the 
inhibition of replication. Without the replication of its DNA, the cell would not 
be able to divide properly. If the mutated DNA was to be used for transcription 
then it could result in the production of an improper sequence of mRNA. If the 
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improper sequence of RNA is transcribed then the amino acid sequences will 
be altered during translation. This can result in absent or malfunctioning 
proteins, many of which are crucial to cell survival. Most forms of DNA 
damage would ultimately result in the death of the cell or under severe damage, 
the whole organism (40). 
 
 
DNA repair pathways 
Damage to DNA can initiate a DNA repair pathway. Before the DNA can 
be repaired the cell cycle is first arrested. Once the cell cycle has been stopped, 
several proteins will then begin to repair the damaged DNA. Once the DNA 
has been repaired, the cell cycle will then continue as normal. These are 
complex pathways and they involve many different proteins  and steps. 
For example, in the case of a DNA single or double strand break, various 
proteins can recognize the break and initiate different DNA damage response 
pathways. The proteins Ataxia telangiectasia mutated (ATM) or ataxia 
telangiectasia Rad3 (ATR) recognize the lesion and can phosphorylate the 
histone variant H2AX. The phosphorylated H2AX is called γ-H2AX. γ-H2AX 
then phosphorylates ATM, which in turn can activate several other 
downstream proteins such as Breast Cancer 1 (BRCA1), p53 binding pair 1 
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(53BP1) and check point kinases 1 and 2(CHK1/2); as shown in figure 2. 
These proteins are involved with initiating the cellular response to DNA DSBs, 
but each plays a different role (2, 11, 19, 25). 
CHK proteins can phosphorylate the cell division cycle 2 (cdc2) proteins. 
Cdc2 is a CDK, and it becomes inhibited when it’s phosphorylated by the CHK 
protein. When cdc2 is inhibited the cell can not proceed to the next stage, 
leading to cell cycle arrest.  
The 53BP1 is responsible for phosphorylating and activating p53 which can 
also play a role in cell cycle arrest. Shortly after p53 becomes 
phosphorylated it leads to an up-regulation of p21, which 
leads to G1-S phase arrest. After the cell cycle has been 
arrested, BRCA1 can participate in the repair of the damaged DNA, but its 
mechanism is not completely understood. Akt1, a pro-survival protein, 
can also be linked to repair pathways by helping initiate repair 
which ultimately leads to cell survival (4, 7). 
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Figure 2. Proposed double strand break response pathway.  A 
double strand break is detected and can lead to the activation of 
several different proteins. Through a series of protein phosphorylations 
the cell cycle arrests and DNA repair begins. 
[http://www.nature.com/ncb/journal/v4/n12/fig_tab/ncb1202-
e277_F1.html] 
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Akt1 (also known as Protein Kinase B) is a kinase that promotes cellular 
growth and proliferation. When a growth factor binds to its receptor it 
produces PI3K (phosphoinositide 3-kinase) which recruits Akt1 to the cell 
membrane where it is phosphorylated by PDK-1 and PDK-2 
(phosphoinositide-dependent kinase). Once Akt-1 has been phosphorylated it 
will phosphorylate several proteins which lead to gene transcription. This will 
lead to the activation of several genes associated with cell growth (mTOR, 
survivin, NF-Kappa B) and inhibition of genes associated with apoptosis 
(BAD, BAX) (27). Many tumors can arise from over expression of Akt1, and 
even cause cancers (10, 36). One important gene that Akt1 can activate is 
MDM2. This protein will bind to p53, inhibit it, and eventually lead to its 
degradation by ubiquitination. This pathway is depicted in figure 3. This is one 
of the major reasons some tumors can grow out of control, as without p53 there 
is little that can stop the cells from growing (32). By blocking the Akt1 
pathway, it may enable the tumorgenic cells to become sensitized to p53 and 
ultimately undergo apoptosis (17, 18, 29, 30). 
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Figure 3. Akt1 pathways. Growth hormone binds to its receptor and leads 
to the activation of PI3K. The activated PI3K then activates PI 3-4-5 P, which 
then phosphorylates Akt1. This phosphorylation of Akt1 can cause several 
other proteins to be activated or inhibited. Mdm2 is an important protein 
because its phosphorylation can lead to the destruction of p53. p53 can activate 
phosphatase and tensin homolog (PTEN), which inhibits the activation of PI 3-
4-5 P. As a result cell survival is maintained and apoptosis is inhibited. 
[http://p53.free.fr/p53_info/p53_cancer.html] 
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Apoptotic response pathways 
 
Sometimes a cell will not be able to repair DNA damage. This will result in 
a different response pathway known as the apoptotic pathway. Similar to the 
DNA repair response, the apoptotic response can involve several different 
pathways involving many different proteins. p53 is one of, if not the 
most important tumor suppressor protein and is often 
responsible for initiating apoptosis. There are two main apoptotic 
pathways, the intrinsic and extrinsic pathway and p53 is involved in both (35). 
In the intrinsic pathway p53 can play a role by activating 
pro-apoptotic genes such as BCL-2 associated X protein (BAX), 
p53 unregulated modulator of apoptosis (PUMA) and FAS 
receptor. The expression of PUMA is regulated by p53 and its 
increased levels lead to apoptosis. PUMA affects the 
mitochondria of the cell by leading to the expression of BAX. 
BAX belongs to the BCL-2 (B cell lymphoma 2) family of pro- 
or anti-apoptotic proteins that regulate the outer 
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mitochondrial membrane. Although these pathways are not 
completely understood, it is believed that certain signals can 
activate or inhibit specific members of the BCL-2 family 
causing a change in the mitochondrial membrane permeability 
(45). 
As the mitochondrial membrane becomes more permeable, 
it will lead to the release of cytochrome C from the 
mitochondria. Cytochrome C is usually involved in oxidative 
phosphorylation, but it can initiate apoptosis when it is 
released from the mitochondria into the cytoplasm. Outside of 
the mitochondria, the cytochrome C binds with apoptotic 
protease activating factor 1 (Apaf-1) and the nucleotide dATP 
forming a ternary protein called an apoptosome. The 
apoptosome can then bind to and cleave caspase-9, which can 
activate other caspases leading to apoptosis (1). This pathway 
is depicted in figure 4. 
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Figure 4. Proposed model of some possible 
intrinsic apoptotic pathways. As a result of DNA 
damage, oncogene expression or stress an intrinsic 
apoptotic pathway may be initiated. p53 becomes active 
which can result in apoptosis through pathways involving 
other proteins and the mitochondria.  
[http://www.biochemsoctrans.org/bst/029/0684/bst0290684f01.htm] 
 
 
The extrinsic pathway of apoptosis can also be initiated 
by p53 by up-regulating FAS-L transcription/translation. When 
FAS ligand (FAS-L) binds to the FAS receptor on the plasma 
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membrane it induces trimerization of Fas and the recruitment of Fas-
associated protein with death domain (FADD) via interactions between the 
death domains of Fas and FADD. The C terminal death domain is the part of 
the protein that interacts with the FAS receptor, and the N terminal death 
effector domain (DED) recruits and cleaves procaspase 8. Procaspase 8 binds 
to the DED of FADD which leads to the activation of caspase 8. Activated 
caspase 8 can lead to apoptosis in one of two ways. 
The first way is by directly cleaving pro-caspase 3, which produces 
caspase 3. Caspase 3 then cleaves inhibitor of Caspase Activated 
Deoxyribonuclease (ICAD), which leads to the release of Caspase Activated 
Deoxyribonuclease (CAD). CAD then enters the nucleus and cleaves the DNA, 
leading to apoptosis. The second way caspase 8 can initiate apoptosis is by 
cleaving the protein BH3 interacting domain death agonist [BID], leading to its 
truncated version tBID. tBID then binds to mitochondrial receptors which lead 
to the release of cytochrome C. Outside of the mitochondria 
cytochrome c binds with Apaf-1 and dATP forming an 
apoptosome. The apoptosome can then bind to and cleave 
caspase-9, which once activated can activate other caspases 
leading to apoptosis. These pathways are shown in figure 5. 
This second pathway incorporates some of the intrinsic 
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pathway, which shows that there are many different apoptotic 
pathways and some of them can crosstalk (13). 
                                        
    
Figure 5. Fas apoptotic pathways. When Fas Ligand 
binds to Fas it recruits FADD, which then cleaves pro-Caspase-
8 forming caspase-8. Caspase-8 can either directly cleave pro-
caspase-3 or it can indirectly by incorporating the 
mitochondria. Capsase-3 can then initiates apoptosis. 
[http://www.biochemsoctrans.org/bst/029/0684/bst0290684f01.htm] 
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One thing in common with most of these responses is the involvement of 
the p53 protein. p53 can be involved in both the repair and apoptotic 
pathway and often is responsible for the transition from repair 
to cell death. Although the mechanism is uncertain, it is 
believed that there is some sort of p53 threshold that initiates 
this transition. When a certain amount of p53 accumulates 
over time the transition from DNA repair to the apoptotic 
pathway will be initiated. This would explain why apoptosis is 
initiated after repair fails. If repair is successful then p53 will 
be degraded, but if repair fails then p53 will continue to 
accumulate and apoptosis will eventually be initiated (20,26). 
Although p53 is the main initiator of the apoptotic pathway, 
the pathway can still be initiated in its absence. p53 deficient 
cells can still undergo apoptosis. This indicates that there are 
p53-independent apoptotic pathwaysp53. One such pathway is 
the Jun N-terminal Kinase (JNK) p38 pathway. After exposure 
to UV light or cisplatin, DNA adducts begin to accumulate, 
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which lead to the activation of p38 and JNK. As p38 and JNK 
levels increase they lead to the up-regulation of activator 
protein-1 (AP-1). AP-1 causes an up-regulation of FAS-L which 
in turn initiates apoptosis. This pathway is shown in figure 6. 
Several experiments have been performed that help support 
this theory by showing that: 1) cells that have been treated 
with inhibitors of JNK and/or p38 inhibit cisplatin induced 
apoptosis and 2) cells that have been treated with FAS 
inhibitors exhibit decreased cisplatin induced apoptosis (24, 
27, 32). 
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Figure 6. JNK/p38 Apoptotic Pathway. UV light or 
cisplatin exposure causes the formation of DNA adducts. These 
adducts lead to a rise in JNK and p38, which in turn lead to an 
up-regulation of AP-1. Ap-1 leads to the transcription of FAS-
L, which will lead to apoptosis. 
Male reproductive tract and gametogenesis 
 
 The male reproductive tract is comprised of four main 
sections: the testes are responsible for producing sperm, the 
epididymis is where spermatozoa undergo maturation, the penis 
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which is where urine and semen are released, and the ductus 
deferens which is the tube in which semen is transported to the 
penis. In addition there are several accessory glands located 
along the male reproductive tract. The prostate gland and the 
seminal vesicles store and produce a clear, slightly alkaline fluid 
that combines with sperm to form semen. The alkalinity aids in 
neutralizing the acidic fluids of the vaginal tract, therefore 
increasing the odds of the sperm surviving. The prostate also 
helps regulate the flow of urine from the bladder to the penis. 
The mouse also has a preputial gland that is responsible for 
releasing pheromones, which are chemicals that are used to 
attract a female mouse. These tissues are shown in figure 7. 
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Figure 7. Over view of the male mouse reproductive tract.  
[http://www.informatics.jax.org/greenbook/figures/figure13-
45.shtml] 
 
 
 The sperm cells are produced in the testes within the coiled 
seminiferous tubules. The seminiferous tubules are lined with 
Sertoli cells that facilitate the development of sperm cells. The 
sperm first begin as mitotic germinal cells called spermatogonia 
that are located near the basal lamina. Once the germinal cell 
has divided several times, it will begin to migrate toward the 
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lumen and will become a primary spermatocyte. In order to 
continue toward the lumen the spermatogonia have to be able to 
pass through tight junctions between Sertoli cells. The Sertoli 
cells are very tightly joined and very few things can pass 
between them. Primary spermatocytes will replicate DNA, and 
will begin to undergo meiosis I. After meiosis I the cells will be 
haploid secondary spermatocytes. These cells will undergo 
meiosis II and will result in four haploid cells called spermatids. 
As the spermatids continue to migrate toward the lumen of the 
seminiferous tubule they begin to grow a tail, shed excess 
cytoplasm and membrane, and begin to develop an acrosome ( a 
part of the sperm head that contains enzymes used to break 
down the eggs membrane).  Eventually the spermatids will 
become spermatozoa and will be released into the lumen of the 
semeniferous tubules. The spermatozoa will travel down the 
lumen until they reach the epididymis where they will fully 
mature into spermatids. This development is shown in figure 
8.When the male ejaculates, the sperm will travel from the 
epididymus down the ductus deferens and out the penis.  
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 Sperm production is tightly monitored by Sertoli cells, 
which provide structural and secretory support. Sperm cells 
develop between the Sertoli cells but they must first pass 
through the tightly regulated blood-testis barrier. The barrier 
consists of the tight junction between two Sertoli cells and is 
responsible for keeping the developing germ cells away from the 
blood stream. Since meiosis produces haploid cells, the germ 
cells are genetically different from the rest of the somatic cells 
and the body’s immune system may recognize them as foreign 
cells and could attack them.  
In addition to structurally supporting the germ cells, the 
Sertoli cells provide the developing germ cells with the chemicals 
and nutrients they need in order properly develop. Some of these 
include inhibins & activins that inhibit or lead to the production of 
follicle stimulating hormones (FSH) respectively. FSH is produced 
in the anterior pituitary gland and is controlled by the release of 
gonadotropin releasing hormone (GnRH) from the hypothalamus. 
FSH stimulates the Sertoli cells to produce androgen-binding 
protein (ABP). ABP is a glycoprotein that binds to androgen 
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hormones (AH) such as testosterone (T) or dihydrotestosterone 
(DHT). The binding of these proteins causes them to become less 
lipophilic, resulting in a higher concentration of T and DHT in the 
testes. T and DHT are required for sperm production, so having a 
high concentration of them within the tubules is very important.  
Although the Sertoli cells are responsible for supplying the 
germ cells with T and DHT, these hormones are not produced 
within the Sertoli cells. Androgen hormones (AH) are produced in 
the Leydig cells that surround the seminiferous tubules in the 
insterstitial tissue. Their production is stimulated by the release 
of Luteinizing Hormone (LH) from the anterior pituitary gland. LH 
increases the activity of the cholesterol desmolase, which 
converts cholesterol to pregnenolone, which will eventually be 
converted to T after a series of reactions. The release of FSH also 
affects the Leydig cells by upregulating LH receptors (LHR), 
therefore leading to increased androgen production.  
Sperm production is a tightly regulated process which involves 
several negative feedback loops between the hypothalamus, 
pituitary gland, Leydig and Sertoli cells. As androgen levels 
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decrease it the hypothalamus produces additional GnRH, 
stimulating the pituitary gland to produce more LH and FSH. The 
increased levels of LH and FSH lead to increased production of 
androgen hormones that aid in spermatogenesis. If any of the 
androgen hormone (AH) levels become too high, the 
hypothalamus will recognize it, it will stop producing GnRH, 
which will lead to lower AH levels (9, 14). 
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Figure 8. Testis and Spermatogenesis. A cross section 
of a testicle shows many coiled seminiferous tubules. Inside 
the tubules sperm are being produced. Sperm start as a 
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diploid, germinal cell that eventually mature into haploid 
spermatozoa. 
[http://faculty.sunydutchess.edu/Scala/Bio102/PDF/Sperma
togenesis.jpg] 
Summary and Hypothesis 
p53 is a major participant of cell cycle arrest and apoptotic 
signaling pathways. Akt1 plays the opposite role, as it initiates 
growth and proliferation and can indirectly inhibit p53. 
Although p53 and Akt1 play opposite roles, both are important 
in the response to DNA lesions.  If either protein malfunctions 
it can lead to many problems, one being cancer. If Akt1 is 
mutated it can lead to improper DNA repair or uncontrolled 
proliferation, and p53 that is impaired can not assist in 
initiating DNA repair or apoptosis.  
Many treatments of testicular cancer can cause the 
patient permanent testicular injury and in some cases sterility. 
By manipulating p53 or Akt1 it may be possible to initiate 
apoptosis and cause the desired cancerous cells to die. If p53 
functions in germ cells the same way it does in somatic cells, 
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in theory it may be possible to treat testicular cancer by 
causing the tumor cells to stop growing and undergo 
apoptosis. By comparing how relative p53 and apoptotic levels 
change over time it will help to better understand the 
importance of p53 in germ cell apoptotic pathways. My 
hypothesis is that p53 levels and consequently apoptotic levels 
will increase (especially in the p53 wild type group compared 
to the knockout one) after induced DNA damage. This 
research will hopefully aid in the understanding of the p53 
protein, and possibly help in future treatments of cancer (6, 
17, 29). 
Chapter 2. Effect of Radiation Exposure on p53 in 
Mouse Germ Cells 
 
Ionizing radiation is composed of energized waves of particles, released from 
an atom or nucleus that can ionize an atom through atomic interactions. Some of 
these particles can include photons (γ radiation), electrons (β radiation), and alpha 
particles (α radiation).  α and β radiation are not very penetrating and can be easily 
deflected. Since α and β radiation can barely penetrate, they will be more 
dangerous if they are trapped inside the body.  γ radiation is less ionizing but 
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requires more extensive shielding since it is more penetrating. These particles are 
only considered to be ionizing if they have enough energy and if they actually 
interact with an atom (42). 
These interactions can lead to the gain or loss of an electron, therefore altering 
the atom to have a different charge. If the atom is to gain an electron, the electron 
must have enough energy to pass the highest shell of the atom. If it does pass the 
barrier the electron will eventually emit the excess energy and will remain at its 
lowest energy state. If the electron does not pass the barrier it will be reflected by 
the electrostatic force. In order for the atom to lose an electron, the electron must 
have enough energy to pass over or through the highest potential orbital. If an 
electron becomes excited but does not have enough energy to pass the potential 
barrier it will temporarily remain at the closest orbital. The electron will 
eventually radiate out the absorbed energy, and will return to its original state.  
When DNA is irradiated its atoms can undergo a change in charge, which will 
in turn cause a change in the molecule’s interactions. These changes can cause the 
DNA molecules to bind improperly, resulting in a DNA lesion or strand break. 
The damaged DNA will lead to one of three fates for the cell. The first is the 
damage is recognized and the cell will be able to repair it. The second fate is that 
the damage is too extensive and repair will fail; as a result the cell will undergo 
apoptosis. The third fate is that the lesion goes unrecognized and will remain in 
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the DNA resulting in a mutation. This is a typical response if p53 is mutated or 
absent. One mutation may not be harmful but several mutations can accumulate 
over time. Eventually enough mutations can occur that the cell becomes cancerous 
and can lead to a tumor. For the purposes of these experiments radiation will be 
used to induce apoptosis in testicular cells (15, 16, 17, 42). 
 
 
 
 
 
 
Materials and Methods 
Animals- p53 deficient and wild type mice were obtained by breeding p53 
heterozygous mice (strain B6.129S2-Trp53tm1Tyj) purchased initially from the 
Jackson Laboratory (Bar Harbor, ME). Mice were given water and standard lab 
chow ad libitum. The temperature of the animal room was kept at constant room 
temperature (23.3 ± 2 ºC and 30-70% humidity) and exposed to 12 hour 
alternating light and dark cycles. All procedures were performed in accordance 
with Brown University’s institutional animal and use committee in compliance 
with the guidelines established by the NIH.  
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Radiation Exposure- Adult 8-week-old p53 wild-type (+/+), heterozygous (+/-) 
and p53-deficient (-/-) mice were used for experiments. Mice were given half-
body irradiation at a single dose of 5 Gy with a delivery rate of 6.84 Gy/min using 
a cesium source (J.L Sheperd, Mark I Irradiator Glendale, CA). Mice were 
restrained in a polystyrene chamber, and the upper body was shielded using lead. 
Control and irradiated mice were sacrificed by carbon dioxide asphyxiation at 1, 3, 
6, 12 and 24 hours post irradiation, and their testes were extracted. 
 
Western Blotting  - Testes from control,  1, 3, 6, 12, and 24 hour post radiation 
exposed mice were detunicated, weighed, and homogenized in three volumes of 
ice-cold RIPA buffer (50mM Tris pH 7.4, 150mM NaCl, 1% NP-40, 0.5% 
deoxycholate, and 0.1% SDS) containing a protease inhibitor cocktail (P2714, 
Sigma) by 10 strokes in a Dounce homogenizer. Samples were incubated on ice 
for 30 minutes. The homogenate was then centrifuged at 13,500 X g for 10 
minutes at 4°C. For western blotting, 10 µL of testis supernatant were separated by 
molecular weight by10% SDS page, and transferred to Immobilon-P membrane. 
Blocking solution (20mM Tris pH 4.4, 137 mM NaCl, 10% nonfat dry milk) was 
added to the membrane for 60 minutes. Primary antibodies to serine 15 
phosphorylated p53 were diluted in blocking solution and added to the membranes 
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at 4ºC overnight. After washing with PBS 0.1% Tween-20, horseradish 
peroxidase-coupled secondary anti-body diluted in blocking solution were 
incubated with the membranes for 1 hour at room temperature. Membranes were 
washed three times with PBS-Tween (0.1%) and secondary antibody was detected 
by enhanced chemiluminescence according to the manufacturer’s instructions 
(Amersham Pharmacia Biotech).  
 
DNA Extraction for genotyping- At 21 days old, the mice were held between 
thumb and index finger and about ¼ cm of the mouse’s tail was snipped off. The 
DNA was then extracted using a “QIAGEN DNeasy kit.” The tail snip was placed 
in a 1.5 mL microfuge tube with 180 µL ATL (tissue lysis) buffer and 20 µL of 
proteinase K.  The tube was then placed in a temperature bath overnight in order to 
dissolve the tail. The following day 400 µL of AL-ethanol buffer was added and 
the microfuge tube was vortexed. The mixture was then pipetted into the DNeasy 
mini spin column that is placed in a 2mL collection tube and centrifuged at 8000 
rpm for 1 minute. The flow-through and collection tube were discarded and the 
mini spin column was placed in a new collection tube. 500 µL of buffer AW1 
(wash buffer 1) was then added and the tubes were centrifuged again at 8000 rpm 
for 1 minute. The flow-through and collection tube were discarded and the mini 
spin column was again placed in a new collection tube. 500 µL of buffer AW2 
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(wash buffer 2) was then added and the tubes were centrifuged at 14,000 rpm for 3 
minutes. The flow-through and collection tube were then discarded and the mini 
spin column was placed in a new 1.5 mL microfuge tube. 200 µL of DEPC treated 
water was then added to the tube and centrifuged at 8000 rpm for 1 minute. The 
easy spin column was discarded and the extracted DNA was diluted in 200 µL of 
DEPC treated water in a microfuge tube.  
 
Polymerase Chain Reaction (PCR) - DNA extracted from the previous protocol 
was added to several reagents to produce the PCR cocktail. These reagents 
include: DEPC treated water, primers for the p53 gene, magnesium chloride, 
nucleotide bases, PCR buffer solution, and Taq polymerase. Once the mix was 
prepared, 20 µL of it was added to 5µL of DNA, and that solution was pipetted in 
a PCR tube. The tube was then placed in the PCR machine and went through an 
initial cycle of 94ºC for 5 minutes. The machine then goes through a second cycle 
thirty five times which consists of three steps: 94ºC for 30 seconds, 61ºC  for 45 
seconds and 72ºC for 45 seconds. The PCR then went through a third cycle of 
72ºC for 2 minutes and then the final hold of 4ºC.  
 
Apoptosis Staining (Apoptag) - p53 +/+, +/- and -/- mice were sacrificed at 0, 1, 
3, 6, 12 and 24 hours. Their testes were then extracted, embedded in freezing 
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medium and then flash frozen in liquid nitrogen. The testes were then sliced at 10 
µm using a cryostat into thin sections and mounted to slides. 10% neutral buffered 
formalin followed by an ethanol/acetic acid mixture, and finally a 3% hydrogen 
peroxide solution (with a PBS rinse between each step) was used to help fix the 
section to the slide. After the hydrogen peroxide was washed off equilibrium 
buffer was quickly applied to each section, and then blotted dry. Terminal 
Deoxynucleotidyl Transferase (TdT) enzyme was then mixed with reaction buffer 
at a 1:2 ratio and a couple drops were applied to each section. TdT catalyzes the 
addition of nucleotides that are secondarily labeled with a marker onto the fragmented 
DNA associated with apoptosis. Cover slips were then applied to the sections, and 
then they were incubated at 37ºC in a humidification chamber for an hour. The 
slides were then removed from the chamber, rinsed with PBS and then stop buffer 
was added to halt the TdT enzyme reaction. The stop buffer is rinsed off and anti-
digoxigenin-peroxidase was applied to the sections, which were then incubated at 
37ºC in a humidification chamber for 40 minutes. The slides were then removed, 
rinsed off and 3,3'-diaminobenzidide (DAB) was applied in order to add the brown 
stain for apoptosis. After 5 minutes the DAB was washed off and the cells are 
counterstained with methyl green for 10 minutes. The methyl green was then 
rinsed off and the slides are then dipped in isopropanol for 2 minutes. The slides 
were then dipped in Citrosolve clearing agent for 2 minutes and then blotted dry. 
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Cover slips are applied to the sections which are then examined under a light 
microscope. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
Experiment 2.1: Body/Testes weights of irradiated mice 
 
 
Irradiated mice were sacrificed and their body weight (BW) and combined 
testes weight (TW) were measured in grams. The average and standard error of the 
mean for the weights were calculated in each group. The body and testes weights 
did not vary much between groups and there was no statistical difference between 
the groups. Data is shown in table 1. 
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Table 1. The body and combined testes weights ± SEM of mice following 
radiation exposure. BW: body weight, TW: combined testes weight, WT: wild type, 
HET: heterozygous, KO: knockout. Sample size varied from 19 mice for the WT and KO 
and 26 mice in the HET group. Statistical analysis was performed using One way 
ANOVA and Dunnett’s test. 
 
 
 
 
 
 
Experiment 2.2: p53 Levels Over Time in Irradiated Mice 
 
Mouse testes were homogenized and their protein levels were measured by a 
protein assay. The samples were then run through a SDS PAGE gel and using a 
western blot, p53 levels were compared to β-Actin as a standard. Based on the 
western results p53 levels in wild type mice were shown to increase after radiation 
exposure. p53 increased around 3 hours and especially at the 6 hour time point, but 
by 12 hours levels had considerably decreased. By 24 hours the p53 levels 
returned to normal. The concentration units were determined by comparing the 
 WT HET KO 
BW (g) 22.63±0.36 23.16±0.4 23.47±0.4 
TW (g) 0.167±0.004 0.179±0.004 0.183±0.005 
Formatted Table
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protein levels at the time point to the initial amount (For example the 2.6 
concentration at time point 3hrs means that p53 levels were 2.6 times as much as 
the amount at the initial 0 hr time point). This data is shown in figure 9. 
 
 
 
 
 
 
 
 
A  Time (hrs)     0          0        1       1        3      3      6        12    24     24 
B 
       
p53 
Β-Actin 
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Figure 9. Western gel for p53 levels at varying time intervals post radiation. 
A. Picture of a western blot for p53 and β-Actin concentrations at several hours after 
radiation exposure. B. p53 levels increase at 3 hours and 6 hours. Levels then decrease 
between 12-24 hours, until p53 levels return to normal. Same size varied from 1-2 mice 
as depicted in the above blot. 
 
 
 
 
 
Experiment 2.3. Apoptotic levels in irradiated mice testes 
 
Mouse testes were frozen in tissue freezing medium and sections were sliced at 
10 µm at minus 15 degrees Celsius onto slides using a Jung 5000 brand cryostat 
(***). The slides were stained for apoptosis using an apoptag (TUNEL) staining 
kit. The incidence of apoptosis in radiation treated mouse testis was determined by 
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counting the number of seminiferous tubules in cross sections of testis which 
exhibited more than 4 cells that have undergone apoptosis. For each genotype/time 
point between 6 and 10 tubules were observed. Apoptag results showed increased 
apoptosis levels in all genotypes after radiation exposure. Apoptotic levels didn’t 
increase much until about a 2 fold change around the 6 hour time points, and then 
increased several fold at 12 hours. By 24 hours apoptotic levels began to decrease 
but were still relatively high. Generally the WT mice had the highest amount of 
apoptosis, followed by the HET group, and the KO mice had the least amount of 
apoptosis. 
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Figure 10. Apoptotic levels at varying time intervals post radiation. 
 A. Pictures of tubule cross sections at 12 hours after radiation exposure for p53 
wild type and knockout mice. B. Representative examples (from a sample size of 3 
mice for each bar) of TUNEL stained testis sections from p53 +/+ and p53 -/- are shown 
above.  The percentage of seminiferous tubules in each treatment group which exhibited 
more than 4 TUNEL positive cells is plotted against the Time after treatment. Each bar 
represents the average of 6-10 testis sections from 2-3 mice. Statistical analysis was 
performed using One way ANOVA and Dunnett’s test.  *p<0.05, ^p<0.01 compared to 
the p53 +/+ group. 
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Conclusion 
 
The results of the experiments indicate that p53 is affected by ionizing 
radiation. Using the Apoptag kit, apoptotic levels were observed. The sections 
showed that several hours post irradiation there was an increase in apoptotic levels 
in all 3 genotypes, but significantly less apoptosis in mice that were deficient of 
p53 compared to the wild type. These results further support that p53 is an 
important apoptotic factor, and without it apoptosis is greatly inhibited.  
The Western blot results showed that p53 levels began to increase around 3 
hours up to 6-12 hours post irradiation, and then begin to decrease afterward. 
These results support the hypothesis that p53 is being up-regulated to perform cell 
cycle arrest/apoptosis, and then down-regulated after repair or apoptosis has been 
completed. 
Based upon the results, p53 does play a major role in initiating radiation 
induced apoptosis in mouse germ cells. Apoptosis still did occur in p53 KO mice, 
which means that apoptosis does still occur in the absence of p53 but its levels are 
considerably decreased. 
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Chapter 3. Effect of cisplatin exposure on p53 in mouse 
germ cells 
 
Cisplatin is a platinum based chemotherapy drug that is 
used to treat many types of cancer. Cisplatin has a central 
platinum atom that is bonded to two chlorine atoms and two 
ammonia molecules. Cisplatin is administered intravenously in 
a saline solution. While in the bloodstream the high amounts 
of chloride ions enable the cisplatin to remain inactive. 
Cisplatin can then be absorbed into the cell by either passive 
diffusion or active transport (34). 
Once the cisplatin is inside the cell where there is a much 
lower chloride concentration, the lower chloride concentration 
and high water concentrations allow one of the chlorine atoms 
to become displaced with a water molecule, resulting in the 
charged molecule [PtCl(H2O)(NH3)2]+ . The water molecule that is 
attached can become replaced with one of the nitrogen groups 
in DNA that is not bound to any hydrogen atoms. This 
displacement can result in the molecule being linked to the 
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DNA strand. Once the cisplatin is attached to a base, the other 
chlorine atom will become displaced with another water 
molecule enabling it to bind to a different base. The double 
binding of cisplatin can result in either intra or inter strand 
cross-linkage. This crosslink can interfere with the replication 
process by blocking the action of DNA polymerase. This arrest 
of DNA polymerase then initiates the DNA repair pathways, 
which will attempt to replace the linked nucleotides. The 
cisplatin molecule is strongly bound to the DNA and it is 
unlikely that the cell will be able to repair the DNA damage. 
The failure to repair the damaged DNA will eventually result in 
the initiation of the apoptotic pathways and the ultimate death 
of the cell (33,41).  
Cisplatin is used to treat cancer by preventing replication 
and initiating apoptosis in the affected cells. Since the DNA 
crosslink is noticed during replication, the constantly 
replicating cancer cells are more likely to be affected by the 
cisplatin treatment. Also the faster dividing cells have a 
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smaller window of time for repair, so it takes less time for 
apoptosis to be initiated (21).  
 Although cisplatin may kill the cancerous cells, it can also 
affect normal cells in the body, which may lead to several 
possible side effects. Some of these effects include: kidney 
and nerve damage, hair and hearing loss, nausea, sterility, 
vomiting and electrolyte loss. Many of these side effects can 
be treated with medicine and supplements but unfortunately 
some may not and can result in permanent organ failure (34).  
Cisplatin will be used in this study to induce strand cross-
links in the DNA. The cross-links will initiate DNA repair and 
apoptosis so that the role of p53 in the apoptotic pathways 
can be better understood. It would be expected that p53 
deficient mice will be more resistant to repair and apoptosis, 
since p53 is a major participant in both the DNA repair and the 
apoptotic pathways (44). 
 
 Figure 11. Cisplatin molecule. The cisplatin molecule is 
composed of a central 
chlorine atoms, and a pair of ammonia molecules.
 
Animals- p53 deficient and wild type mice were obtained by breeding p53 
heterozygous mice (strain B6.129S2
Jackson Laboratory (Bar Harbor,
chow ad libitum. The temperature of the animal room was kept at constant room 
temperature (23.3 ± 2 ºC and 30
alternating light and dark cycles. All procedures were performed in accordance 
with Rhode Island College’s institutional animal and use committee in compliance 
with the guidelines established by the NIH. 
  
Cisplatin Exposure- 60 day old mice were administer
0.9% saline solution via 
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platinum atom bonded to a pair of 
 
  
 
 
 
 
Materials and Methods 
 
-Trp53tm1Tyj) purchased initially from the 
 ME). Mice were given water and standard lab 
-70% humidity) and exposed to 12 hour 
 
ed 10mg/kg of cisplatin in 
I.P. injection. Cisplatin exposed mice were then sacrificed 
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by carbon dioxide asphyxiation at varying time points: 24, 48 and 72 hours post 
injection, and their testes were extracted. 
Western Blotting  - Testes from control, 24,  48 and 72 hour post cisplatin 
exposed mice were detunicated, weighed, and homogenized in three volumes of 
ice-cold RIPA buffer (50mM Tris pH 7.4, 150mM NaCl, 1% NP-40, 0.5% 
deoxycholate, and 0.1% SDS) containing a protease inhibitor cocktail (P2714, 
Sigma) by 10 strokes in a Dounce homogenizer. Samples were incubated on ice 
for 30 minutes. The homogenate was then centrifuged at 13,500 X g for 10 
minutes at 4°C. For western blotting, 10 µL of testis supernatant were separated by 
molecular weight by10% SDS page, and transferred to Immobilon-P membrane. 
Blocking solution (20mM Tris pH 4.4, 137 mM NaCl, 10% nonfat dry milk) was 
added to the membrane for 60 minutes. Primary antibodies to serine 15 
phosphorylated p53 and Vinculin were diluted in blocking solution and added to 
the membranes at 4ºC overnight. After washing with PBS 0.1% Tween-20, 
horseradish peroxidase-coupled secondary anti-body diluted in blocking solution 
were incubated with the membranes for 1 hour at room temperature. Membranes 
were washed three times with PBS-Tween (0.1%) and secondary antibody was 
detected by enhanced chemiluminescence according to the manufacturer’s 
instructions (Amersham Pharmacia Biotech). 
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DNA extraction for genotyping- At 21 days old, the mice were held between 
thumb and index finger and about ¼ cm of the mouse’s tail was snipped off. The 
DNA was then extracted using a “QIAGEN DNeasy kit.” The tail snip was placed 
in a 1.5 mL microfuge tube with 180 µL ATL (tissue lysis) buffer and 20 µL of 
proteinase K.  The tube was then placed in a temperature bath overnight in order to 
dissolve the tail. The following day 400 µL of AL-ethanol buffer was added and 
the microfuge tube was vortexed. The mixture was then pipetted into the DNeasy 
mini spin column that is placed in a 2mL collection tube and centrifuged at 8000 
rpm for 1 minute. The flow-through and collection tube were discarded and the 
mini spin column was placed in a new collection tube. 500 µL of buffer AW1 
(wash buffer 1) was then added and the tubes were centrifuged again at 8000 rpm 
for 1 minute. The flow-through and collection tube were discarded and the mini 
spin column was again placed in a new collection tube. 500 µL of buffer AW2 
(wash buffer 2) was then added and the tubes were centrifuged at 14,000 rpm for 3 
minutes. The flow-through and collection tube were then discarded and the mini 
spin column was placed in a new 1.5 mL microfuge tube. 200 µL of DEPC treated 
water was then added to the tube and centrifuged at 8000 rpm for 1 minute. The 
easy spin column was discarded and the extracted DNA was diluted in 200 µL of 
DEPC treated water in a microfuge tube.  
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Polymerase Chain Reaction (PCR) - DNA extracted from the previous protocol 
was added to several reagents to produce the PCR cocktail. These reagents 
include: DEPC treated water, primers for the p53 gene, magnesium chloride, 
nucleotide bases, PCR buffer solution, and Taq polymerase. Once the mix was 
prepared, 20 µL of it was added to 5µL of DNA, and that solution was pipetted in 
a PCR tube. The tube was then placed in the PCR machine and went through an 
initial cycle of 94ºC for 5 minutes. The machine then goes through a second cycle 
thirty five times which consists of three steps: 94ºC for 30 seconds, 61ºC  for 45 
seconds and 72ºC for 45 seconds. The PCR then went through a third cycle of 
72ºC for 2 minutes and then the final hold of 4ºC.  
 
Apoptosis Staining (Apoptag) - p53 wild type, heterozygous, and knockout mice 
were sacrificed at 0, 24, 48 and 72 hours after cisplatin exposure. Their testes were 
then extracted, embedded in freezing medium and then flash frozen in liquid 
nitrogen. The testes were then sliced 10 µm thick using a cryostat into thin 
sections and mounted to slides. 10% neutral buffered formalin followed by an 
ethanol/acetic acid mixture, and finally a 3% hydrogen peroxide solution (with a 
PBS rinse between each step) was used to help fix the section to the slide. After 
the hydrogen peroxide was washed off equilibrium buffer was quickly applied to 
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each section, and then blotted dry. Terminal Deoxynucleotidyl Transferase (TdT) 
enzyme was then mixed with reaction buffer at a 1:2 ratio and a couple drops were 
applied to each section. TdT catalyzes the addition of nucleotides that are labeled with 
a marker onto the fragmented DNA associated with apoptosis. Cover slips were 
then applied to the sections, and then they were incubated at 37ºC in a 
humidification chamber for an hour. The slides were then removed from the 
chamber, rinsed with PBS and then stop buffer was added to halt the TdT enzyme 
reaction. The stop buffer is rinsed off and anti-digoxigenin-peroxidase was applied 
to the sections, which were then incubated at 37ºC in a humidification chamber for 
40 minutes. The slides were then removed, rinsed off and 3,3'-diaminobenzidide 
(DAB) was applied in order to add the brown stain for apoptosis. After 5 minutes 
the DAB was washed off and the cells are counterstained with methyl green for 10 
minutes. The methyl green was then rinsed off and the slides are then dipped in 
isopropanol for 2 minutes. The slides were then dipped in Citrosolve clearing 
agent for 2 minutes and then blotted dry. Cover slips are applied to the sections 
which are then looked at under a light microscope. 
 
Cisplatin Results 
 
Experiment 3.1: Body/Testes weights for cisplatin exposed mice 
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Cisplatin injected mice were sacrificed and their body weight (BW) and testes 
weight (TW) were measured. The average and standard error of the mean (SEM) 
were calculated for each group. The body weights did not vary between groups but 
the testes weights did. It appears that the testes weights were greatest in the KO 
groups, and the WT and HET groups were about the same. This data is shown in 
table 2.  
 
 
 
 
 
 
Table 2. Body and testes weights ± SEM of mice following cisplatin 
exposure. BW: body weight, TW: combined testes weight, WT: wild type, 
HET: heterozygous, KO: knockout. Same size was 7 mice for each 
genotype group. Statistical analysis was performed using One way ANOVA and 
Dunnett’s test.  *p<0.05 compared to the p53 +/+ group 
 
 
 
Experiment 3.2:  p53 protein levels in cisplatin exposed mice  
 
 WT HET KO 
BW 26.82 26.39 27.52 
BW 
SEM 0.77 1.35 0.593 
TW 0.092 0.091 0.11 
TW 
SEM 0.0041 0.0035 0.0027 
 WT HET KO 
BW (g) 26.82±0.77 26.39±1.35 27.52±0.593 
TW (g) 0.092±0.004 0.091±0.004   0.11±0.003 * 
Formatted Table
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Mouse testes were homogenized and their protein levels were measured by 
assay. The samples were then run on a SDS gel and western blotted to compare 
p53 levels at varying time intervals using vinculin as a standard.  
Based on the western results p53 levels in wild type mice were shown to 
increase after cisplatin exposure. p53 levels started out low and by 24 hours they 
started to increase. p53 levels then increased more by 48 hours and then began to 
decrease at 72 hours. This data is displayed in figure 13. 
 
 
 
 
 
 
 
 
 
 
 
A. 
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Figure 13. Western gel for p53 levels at varying time intervals post cisplatin 
exposure. A. Picture of western blots for p53 and vinculin levels at various hours 
after cisplatin injection. B. p53 levels are low at 0 hrs and then increase at 24 
hours, increase more by 48 hours, and then began to decrease a bit by 72 hours. 
Sample size varied between 3-6 mice per time point, and was run on 2 blots. 
Experiment 3.3 Apoptotic levels in cisplatin exposed mice.  
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Cisplatin exposed p53 +/+, +/- and -/- mice testes were frozen in tissue 
freezing medium and sections were sliced 10 µm thick at minus 15 degrees 
Celsius onto slides using a TBS brand cryostat machine. The slides were stained 
for apoptosis using an Apoptag kit. Apoptag results showed increased apoptosis 
levels in all genotypes after cisplatin exposure. Cisplatin apoptotic levels increased 
around the 24 hour time points, increased more at 48 hours, and then began to 
decrease at 72 hours. The WT mice had the highest amount of apoptosis, followed 
by the heterozygous group, and the KO mice had the least amount of apoptosis. 
This data is shown in figure 12. 
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    p53 +/+ 48 hour    p53 -/- 48 hour   
 
Figure 12. Apoptotic levels at varying time intervals post cisplatin injection 
A. Pictures of tubules 48 hours after cisplatin injection for p53 wild type and knockout 
groups. B. Representative examples (from a sample size of 3 mice for each bar) of 
TUNEL stained testis sections from p53+/+ and p53-/- are shown above.  The percentage 
of seminiferous tubules in each treatment group which exhibited more than 4 TUNEL 
positive cells is plotted against the time after treatment. Each bar represents the average 
of 6-10 testis sections from 2-3 mice.  Statistical analysis was performed using One way 
ANOVA and Dunnett’s test.  *p<0.05 compared to the p53 +/+ group 
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Conclusion 
 
The results of the experiments indicate that p53 and apoptotic levels are 
affected by cisplatin. Using the Apoptag kit, apoptotic levels were observed. The 
sections showed that 24+ hours post injection there was significantly less 
apoptosis in mice that were deficient of p53 compared to the wild type. These 
results further support that p53 is an important apoptotic factor, and without it 
apoptosis can be inhibited.  
The Western results showed that p53 levels increased in response to cisplatin 
exposure.  Levels began to increase 24 hours after cisplatin exposure, increased 
even more by 48 hours and then began to decrease by 72 hours. These results 
support that hypothesis that p53 is being up-regulated to perform cell cycle 
arrest/apoptosis, and then down-regulated after repair or apoptosis has been 
completed. 
Based upon the results, p53 does play a role in initiating cisplatin induced 
apoptosis in mouse germ cells. Apoptosis still did occur in p53 KO mice, which 
means that apoptosis does still occur in the absence of p53 but its levels are 
considerably decreased. 
  
 
 53
Chapter 4.   Discussion 
 
Testes and Body Weights 
 
 Shortly after being sacrificed the mice had their body weights and testes 
weights measured and recorded in grams. The mean (+/- SEM)  body and testes 
weights were calculated for each group. This was done to see if apoptosis had an 
effect on testes or body mass. In the radiation exposed group the body and testes 
weights did not vary greatly between groups. Although there was no significant 
difference, it appeared that the KO weights were greater than the other groups. 
The body weights in the cisplatin treated groups were generally greater than the 
ones in the radiation group, but the testes weights in the cisplatin group were 
generally less than the ones in the radiation group. Cisplatin exposure leads to 
significantly decreased testis weight and could explain the difference between the 
groups (34). The body weights in the cisplatin group were about the same, but the 
testes weights were not. The testes weights in the KO group were significantly 
higher than in the WT or Het groups. A possible explanation is that apoptosis 
would lead to decreased testis weights due to the loss of germ cells. This would 
explain why the KO groups (which had overall less apoptosis) would also weigh 
the most. 
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Table 3. The body and testes weights of sacrificed mice. 
Mean ± SEM body weight and combined testes weights for mice treated with 
radiation or cisplatin. BW: body weight, TW: testes weight, WT: wild type, HET: 
heterozygous, KO: knockout. Statistical analysis was performed using one way 
ANOVA and Dunnett’s test.  *p<0.05 compared to the p53 +/+ group. 
 
 
 
 
 
Western Blot analysis 
 The western was performed to see how p53 levels changed at varying time 
points after being exposed to stress. By comparing the p53 levels to the apoptotic 
levels at corresponding time points, it will help to better understand the role of p53 
in germ cell apoptosis.  
 The western results for radiation showed that the p53 levels did vary at 
different points post irradiation. The p53 levels began to increase at 3 hours and 
increased even more at 6 hours. At 12 hours p53 levels had decreased and by 24 
hours the levels greatly decreased, and were almost the same as the initial amount.  
 Western results for cisplatin exposure had similar results. p53 levels were 
lowest in the 0 hour group, and by 24 hours the p53 levels began to increase, and 
  
Radiation 
  
Cisplatin 
 
 WT HET KO WT HET KO 
BW 22.63±0.36 23.16±0.4 23.47±0.4 26.82±0.77 26.39±1.35 27.52±0.59 
TW 0.167±0.004 0.179±0.004 0.183±0.005 0.092±0.004 0.091±0.004 0.11±0.003* 
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even increased some more by 48 hours. By 72 hours the p53 levels were still 
elevated but it appeared as if they were beginning to decrease. These results are 
displayed in figure 15. 
 These results show that p53 levels were affected by induced DNA damage. 
After DNA was damaged p53 levels increased until a certain point where the 
levels then began to decrease. This coincides with the theory that p53 is involved 
in DNA repair and/or apoptotic pathways. p53 levels increase in response to DNA 
damage and can initiate apoptosis if damage is too extensive. Once p53’s job is 
done its levels then appear to return back to normal. 
 
Figure 15. p53 levels over time for both groups. Relative concentrations from 
the Western blot data for both radiation and cisplatin groups were combined into 
one graph.  
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Apoptotic Levels  
 The purpose of staining the cells for apoptosis is to better understand the 
time frame of apoptosis after inducing DNA damage and p53’s possible role in it.  
Since p53 is believed to be involved in both cell cycle arrest and initiating 
apoptosis, then if apoptosis is initiated p53 levels should also increase. If a p53 
wild type mouse section shows that apoptosis occurred after stress but the p53 KO 
does not, then it would suggest that p53 plays an important role in apoptosis in the 
testes. The data from the experiments support this hypothesis. Not only did 
apoptotic levels increase after radiation or cisplatin exposure, but there were 
generally increased levels of apoptosis in the WT mice compared to the KO ones.  
For the first few hours in the radiation group the apoptotic levels remained 
about the same. At 6 hours the apoptotic levels began to increase and the 
difference between the WT/HET groups and the KO group begins to increase. At 
12 hours the numbers increased and varied even more among the groups. Finally 
at 24 hours the overall apoptotic levels begin to decrease, and was lower in the KO 
group compared to the other two.  
The cisplatin group had similar results except they were not as extreme. 
The 0 hour group had the least amount of apoptotic levels, the 24 hour group’s 
apoptotic levels began to increase and the differences between the WT/HET 
groups and the KO group also increased. By 48 hours apoptotic levels remained 
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about the same in the WT/HET groups and the KO group began to decrease. 
Finally by 72 hours, apoptotic levels decrease in all three groups, and as expected 
WT group having the highest apoptotic index, HET having the next lower index, 
and the KO group having the lowest. This data is shown in figure 14. 
These results show that apoptotic levels were affected by both the radiation 
and cisplatin exposure, and the groups with p53 had significantly more apoptosis 
than the p53 KO groups. The radiation group’s values were not the same as the 
cisplatin’s but they both had the same overall trend. The least amount of apoptosis 
was in the 0 hr control group and the levels increased over time. Eventually after 
enough time had elapsed the apoptotic levels appeared to decrease. 
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Figure 14. Apoptotic levels at varying time points after exposure. Even though 
the values were different between the radiation and cisplatin groups, they both 
followed the same trend. Apoptotic levels were lowest at 0 hours and started to 
increase over time. Eventually after enough time had passed the apoptotic levels 
started to decrease. p53 levels were also lowest in the p53 -/- groups compared to 
the other two. 
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The Model 
 
 After mouse testicles were exposed to either ionizing radiation or cisplatin 
injection p53 levels increased. Apoptosis levels also increased in response to 
induced DNA damage as well. After enough time had passed after inducing DNA 
damage, apoptotic and p53 levels began to decrease. This decrease indicates that 
p53 and apoptotic levels were returning to normal. 
These results indicate that there is a correlation between p53 and apoptotic 
levels after DNA damage was induced. This coincides with the theory that p53 is 
up-regulated after DNA damage, and if the damage is too extensive then it will 
initiate apoptosis (10, 19, 32, 39). However apoptosis still did occur in the p53 KO 
mice, just not as much compared to the mice not deficient of p53. This indicates 
that although p53 plays an important role in a lot of apoptotic pathways not all 
pathways require it.  A model for possible apoptotic responses to DNA damage is 
shown in figure 16.        
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Figure 16. The Model. A proposed model of how DNA damage can lead 
to apoptosis of cells. DNA damage leads to relatively high levels of apoptosis in 
the testes in p53 WT and HET mice, while p53 KO mice had relatively low levels 
of apoptosis. This shows that p53 plays a major role in most apoptotic pathways. 
However apoptosis can still occur in its absence, which indicates that there are 
some apoptotic pathways that do not require p53. 
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To test this model one could further investigate the apoptotic pathways that 
either incorporate p53 or do not. To further investigate the p53 apoptotic pathway 
one could initiate DNA damage and sacrifice the p53 WT mice at determined time 
intervals. TUNEL staining and western blots could be performed, except for the 
western blots use antibodies targeted against another kinase believed to be 
downstream from p53. If the concentrations of these kinases increased along with 
apoptotic levels it would further support this theory. 
A way one could test the pathway that does not incorporate p53 would be to 
perform TUNEL staining and western blots and use only p53 -/- mice. Different 
antibodies would be used to see the presence of other kinases that may be involved 
in one of the apoptotic pathways. Some possible targets would be JNK, p 38 or 
AP-1. Since the mice would be p53 deficient then apoptosis could only be initiated 
via the pathways that do not incorporate p53. If the levels of these enzymes 
increase after DNA damage is initiated and apoptosis occurs, it would indicate that 
they play a role in the non-p53 apoptotic pathway(s). 
My results coincide with similar published work. In other papers p53 and or 
apoptotic levels increased in response to induced DNA damage in both somatic 
and germ cells. This increase in p53 and apoptotic levels after DNA damage was 
induced also coincides with the theory that p53 plays a major role in apoptotic 
pathways. It is believed that p53 initiates DNA repair, and if it is unsuccessful p53 
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will then initiate apoptotic pathways. Even though most apoptotic pathways are 
believed to incorporate p53 some do not, and apoptosis can still occur, just at 
lower rates (3, 4, 6, 7, 8, 11, 13, 15, 16, 17, 21, 26, 30, 31, 32, 43, 44, 45).  
If it is true that p53 does play a major role in apoptosis in germ cells, then it 
may be possible to induce apoptosis by increasing p53 levels. This could be 
applied in particular to testicular tumors. Tumors arise from constantly growing 
and dividing “immortal” cells. If somehow p53 levels were increased in these 
tumor cells, it may be possible to kill the cells by inducing apoptosis and prevent 
the tumor from growing. Unfortunately some tumors arise from the cells being 
non-responsive to p53. If we could better understand the apoptotic pathway(s) that 
do not incorporate p53, then it may be possible to initiate apoptosis in these cells 
that are resistant to p53. 
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